KR20040032288A - Health food comprising natural Ganoderma Lucidum Karst components and method for the same - Google Patents
Health food comprising natural Ganoderma Lucidum Karst components and method for the same Download PDFInfo
- Publication number
- KR20040032288A KR20040032288A KR1020020061356A KR20020061356A KR20040032288A KR 20040032288 A KR20040032288 A KR 20040032288A KR 1020020061356 A KR1020020061356 A KR 1020020061356A KR 20020061356 A KR20020061356 A KR 20020061356A KR 20040032288 A KR20040032288 A KR 20040032288A
- Authority
- KR
- South Korea
- Prior art keywords
- ganoderma lucidum
- weight
- parts
- natural
- components
- Prior art date
Links
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 19
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 19
- 235000013402 health food Nutrition 0.000 title abstract description 5
- 238000000034 method Methods 0.000 title abstract description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000004310 lactic acid Substances 0.000 claims abstract description 15
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 15
- 241000894006 Bacteria Species 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 11
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 11
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 11
- 239000011425 bamboo Substances 0.000 claims abstract description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 235000015872 dietary supplement Nutrition 0.000 claims description 24
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 10
- 240000006891 Artemisia vulgaris Species 0.000 claims description 10
- 241001330002 Bambuseae Species 0.000 claims description 10
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 3
- 230000004060 metabolic process Effects 0.000 abstract description 13
- 235000013305 food Nutrition 0.000 abstract description 11
- 230000000144 pharmacologic effect Effects 0.000 abstract description 6
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000003803 Torilis japonica Species 0.000 abstract 1
- 241000001727 Tropicoporus linteus Species 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 description 9
- 239000011707 mineral Substances 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 9
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 8
- 229910052698 phosphorus Inorganic materials 0.000 description 8
- 239000011574 phosphorus Substances 0.000 description 8
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 8
- 208000008589 Obesity Diseases 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 6
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 229940100228 acetyl coenzyme a Drugs 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- -1 K + Substances 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 1
- 244000304393 Phlox paniculata Species 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 108010076181 Proinsulin Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- VNWKTOKETHGBQD-AKLPVKDBSA-N carbane Chemical compound [15CH4] VNWKTOKETHGBQD-AKLPVKDBSA-N 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229940036399 choline 350 mg Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- GTZCVFVGUGFEME-HNQUOIGGSA-N cis-Aconitic acid Natural products OC(=O)C\C(C(O)=O)=C/C(O)=O GTZCVFVGUGFEME-HNQUOIGGSA-N 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940021584 osthol Drugs 0.000 description 1
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 영지의 천연 약리성분을 함유하는 건강보조식품에 관한 것으로서, 특히 영지 또는 상황버섯의 고유성분을 유지하면서 기타 천연성분과 조화를 이루어 사람의 신진대사를 촉진시키고, 그 결과 국민의 건강증진에 기여할 수 있는 건강보조식품 및 그 제조방법에 관한 것이다.The present invention relates to health supplements containing natural pharmacological ingredients of Ganoderma lucidum, in particular, while maintaining the intrinsic ingredients of Ganoderma lucidum or situation mushrooms in harmony with other natural ingredients to promote the metabolism of people, as a result of promoting the health of the people The present invention relates to a dietary supplement and a method of manufacturing the same.
최근에는 식생활의 향상으로 사람들의 건강에 대한 관심이 높아짐에 따라, 몸에 좋은 자연식품을 선호하는 경향이 높아지고 있으며, 이에 따라 종래부터 민간요법으로 복용되던 여러가지 자연 식물을 첨가한 건강식품이 개발되고 있다.Recently, as people's interest in health has increased due to improved diet, there is a tendency to prefer natural foods that are good for the body. Accordingly, health foods containing various natural plants that have been conventionally taken by folk medicine have been developed. have.
이와 같은 자연 식물들은 우리나라 뿐만 아니라, 중국 및 일본 등지에서도 오랜 복용의 역사가 있어 식품으로서의 안정성이 충분히 검증되었을 뿐만 아니라, 과학적인 연구를 통하여 그 동안 민간에 구전되어 오던 건강에 대한 효용가치가 밝혀지면서 이의 이용이 꾸준히 증가하고 있다.These natural plants have a long history of taking not only in Korea, but also in China and Japan, so that their stability as foods have been sufficiently verified, and scientific research has revealed the useful value of health that has been given to the public. Usage is steadily increasing.
또한, 최근에는 식품의 고칼로리화로 인한 단순 비만자가 점차로 많아지고 있다. 비만은 각종 질병의 발생에 관여하거나 질병을 악화시킨다. 비만과 관련한 질병으로서는 고혈압, 동맥경화, 지방간 및 당뇨 등을 들 수 있다. 따라서 비만은 미리 예방하는 것이 좋고, 비만증으로 된 경우에는 체지방의 감소를 통하여 신체대사가 원할하게 이루어지도록 하는 것이 중요하다.In addition, in recent years, simple obesity due to high calorieization of food is gradually increasing. Obesity is involved in the development or worsening of various diseases. Obesity-related diseases include high blood pressure, arteriosclerosis, fatty liver and diabetes. Therefore, it is important to prevent obesity in advance, and if obesity becomes important, it is important to make body metabolism smooth by reducing body fat.
비만자는 체중감량에 대한 관심과 노력이 매우 놓으므로, 비만자를 위한 많은 다이어트 방법들이 소개되었고, 또한 이를 위한 다이어트 식품 내지 음료들이 크게 유행하고 있다.Since obesity is very concerned about the weight loss and efforts, many diet methods for obesity have been introduced, and diet foods and beverages for this purpose are in great popularity.
한편, 이와 같은 자연 식물 중에서 영지는 오래전부터 각종 질병에 대한 민간요법제로 널리 알려져 있어, 건강보조식품의 성분으로서 많이 이용되고 있다.On the other hand, among such natural plants, ganoderma has been widely known as a folk remedy for various diseases for a long time, and is widely used as a component of health supplement food.
이러한 영지의 한의학적 효과로는, 혈액을 정화시켜 혈류를 돕고, 혈중의 콜레스테롤 및 기타 노폐물을 제거하고 피를 맑게 해주며, 정력을 높여주고, 인체의 면역기구를 강화 및 정화시켜주며, 중국의 "본초강목"과 "신농본초경"에 따르면 당뇨병, 혈압, 정력보강, 소화기계 질환, 호흡기계 질환 및 간장병에 탁월한 효과가 있는 것으로 알려져 있다.These medicinal effects of the Ganoderma lucidum include blood purification to help blood flow, remove blood cholesterol and other waste products, clear blood, enhance energy, strengthen and cleanse the body's immune system, According to the herbaceous herb "and" neophysiological menarche "is known to have an excellent effect on diabetes, blood pressure, energetic reinforcement, digestive diseases, respiratory diseases and liver disease.
이런 까닭에 영지는 다수종의 건강보조식품으로 개발 및 상품화되었다. 예를 들어 국내 등록특허공보 제10-0143512호(1998.04.09)에는 배양된 영지버섯 균사체로부터 추출 정제되는 면역활성물질이 개시되어 있으며, 등록특허공보 제10-0249757호(1999.12.28)에는 차전자(질경이씨), 포도씨 및 영지를 포함하여 제조되는 건강보조식품이 개시되어 있다.For this reason, ganoderma lucidum was developed and commercialized as a number of health supplements. For example, Korean Patent Publication No. 10-0143512 (1998.04.09) discloses an immunoactive substance extracted and purified from cultured Ganoderma lucidum mycelium, and Patent Publication No. 10-0249757 (December 28, 1999) A dietary supplement is disclosed that includes an electron (plantain seed), grape seed, and ganoderma.
그러나 상술한 바와 같은 종래의 건강보조식품들은 모두 인체내의 일부에 작용하는 지엽적인 효과에만 치중하여 제조 및 공급되는 문제점이 있었다. 즉 암을 치료하는 항암효과, 당뇨병을 치료하는 항당뇨효과에 치중한다거나, 또는 예를 들어 소화기 또는 비뇨기과와 같은 신체내의 일부 기관에만 역점을 둔 제품으로서 제조 및 공급되어 왔다. 또한 이와 같은 지엽적인 건강보조식품은 몸의 전체적인 신진대사를 균형적으로 촉진시키지 못하는 문제점을 수반한다.However, all of the conventional health supplements as described above have a problem in that they are manufactured and supplied focusing only on the side effects acting on a part of the human body. That is, it has been manufactured and supplied as a product focused on the anticancer effect of treating cancer, the antidiabetic effect of treating diabetes, or focused only on some organs in the body such as, for example, the digestive or urology department. In addition, these local health supplements are accompanied by a problem that does not promote the balance of the overall metabolism of the body.
따라서 본 발명은 상기 기술한 바와 같은 종래의 지엽적인 건강보조식품에서 탈피하여, 인체 신진대사의 기본인 TCA 사이클 이론에 근거하여, 인체내의 신진대사를 종합적이고 균형적으로 촉진시킴으로서 건강증진을 도모할 수 있는 천연 약리성분을 함유하는 건강보조식품을 제공하는 것을 그 목적으로 한다.Therefore, the present invention is to escape from the conventional food supplements as described above, based on the TCA cycle theory, which is the basis of human metabolism, to promote health by promoting comprehensive and balanced metabolism in the human body. It is an object of the present invention to provide a dietary supplement containing natural pharmacological ingredients.
상기 목적을 달성하기 위하여, 본 발명의 건강보조식품은 영지 또는 상황버섯, 복령, 인진쑥, 맥주효모 및 죽염의 천연성분을 함유한다.In order to achieve the above object, the health supplement food of the present invention contains natural ingredients of Ganoderma lucidum or situation mushroom, Bokryeong, Injin mugwort, beer yeast and bamboo salt.
상기 영지 또는 상황버섯, 복령, 인진쑥, 맥주효모 및 죽염의 천연성분은 각각 5:2:2:3:0.3의 중량부로 함유될 수 있다.Natural ingredients of the Ganoderma lucidum or situation mushroom, Bokryeong, Injin mugwort, brewer's yeast and bamboo salt may be contained in parts by weight of 5: 2: 2: 3: 0.3, respectively.
또한, 본 발명의 건강보조식품은 유산균 또는 사상자의 천연성분을 더 함유할 수 있으며, 상기 유산균 또는 사상자는 2 중량부 함유된다.In addition, the dietary supplement of the present invention may further contain a natural component of lactic acid bacteria or filamentous, 2 parts by weight of the lactic acid bacteria or filamentous.
본 발명의 건강보조식품은 복령 2 중량부, 인진쑥 2 중량부 및 죽염 0.3 중량부를 분쇄하고, 여기에 맥주효모 3 중량부를 첨가하고, 영지 또는 상황버섯 5 중량부를 추출액으로 하여 흡착시키고 건조하여 과립으로 하고, 유산균 2 중량부를 넣고 환으로 제조할 수 있다.The health supplement of the present invention is crushed 2 parts by weight of Bokryeong, 2 parts by weight of Injin mugwort and 0.3 parts by weight of bamboo salt, and 3 parts by weight of brewer's yeast, and 5 parts by weight of Ganoderma lucidum or situation mushroom as an extract and adsorbed and dried to granules. And 2 weight part of lactic acid bacteria can be put, and it can manufacture in a ring.
인체내에는 약 400조의 세포가 있으며, 각 세포의 미토콘드리아 (Mitochondria) 내에서 에너지 생성을 위한 화학적 순환 과정이 이루어진다. 이러한 순환과정은 TCA 사이클로서 잘 알려져 있다.There are about 400 trillion cells in the human body, and the chemical circulation process for energy generation takes place in the mitochondria of each cell. This cycle is well known as the TCA cycle.
TCA 사이클 이론은 1937년 크렙스(krebs) 경에 의해 완성되었고, 1953년 노벨 의학상을 받은 이론으로서, 인체를 포함하는 동식물체를 종합적인 유기체인 고도의 정밀한 화학공장으로 보고, 이 사이클에 의하여 신진대사가 촉진됨으로써 건강을 유지 및 증진시킬 수 있다고 한 것이다. 여기서, 사이클의 각 단계는 각각 특정한 효소에 의한 촉매작용을 받는다.The TCA cycle theory was completed by Sir Krebs in 1937 and was awarded the Nobel Prize in Medicine in 1953. The plant and plant species, including the human body, are regarded as highly sophisticated chemical plants that are comprehensive organisms. It is said that it is possible to maintain and promote the health by promoting. Here, each step of the cycle is each catalyzed by a specific enzyme.
TCA 사이클은 물질대사에서 가장 중요한 화합물 중의 하나인 아세틸조효소 A(acetyl coenzyme A/Acetyl Co A)가 Mg++ 이온과 반응하여 시트르산을 생성하면서 시작된다. 아세틸조효소 A에서 2개의 탄소로 된 아세틸기는 당·지방산·글리세롤의 불완전 산화에 의해 가장 자주 나타나는 생성물이다. 연속되는 효소의 촉매반응에서 10개의 중간생성물이 만들어지는데, 즉 시스-아코니티산, 이소시트르산, 옥살숙신산, α-케토글루타르산과 이산화탄소, 숙신산과 이산화탄소와 아데노신삼인산(adenosine triphosphate/ATP), 푸마르산, 말산이 이에 해당한다. 이들 가운데 많은 중간 산물들은 세포에 의해 합성되는 화합물에 탄소를 공급하기 위하여 이용된다. 이 사이클은 말산이 옥살로아세트산으로 전환되면서 끝나 새로운 사이클을 시작하게 된다. 이 사이클은 1번의 순환으로 옥살로아세트산을 재형성하고 2분자의 이산화탄소와 15분자의 ATP를 생성한다. 순환과정에서 형성된 중간화합물로부터 이탈한 수소원자는 전자전달계를 통해 최종적으로 산소에 전달된다. 산소에 의한 수소원자의 산화는 호기성 생물이 섭취한 음식물 내에 들어 있는 대량의 에너지를 ATP로 전환·저장시키는 기능을 한다. 산화적 인산화과정으로 알려진 이같은 반응들은 생물체가 이용할 수 있는 에너지 형태인 ATP를 생성하는 가장 중요한 수단이다.The TCA cycle begins when acetyl coenzyme A (Acetyl Co A), one of the most important compounds in metabolism, reacts with Mg ++ ions to produce citric acid. In acetylcoenzyme A, the two-carbon acetyl group is most often the product of incomplete oxidation of sugars, fatty acids and glycerol. Ten intermediates are produced by the subsequent catalysis of enzymes: cis-aconitic acid, isocitric acid, oxalic acid, α-ketoglutaric acid and carbon dioxide, succinic acid, carbon dioxide, and adenosine triphosphate (ATP), and fumaric acid. , Malic acid. Many of these intermediates are used to supply carbon to the compounds synthesized by the cells. The cycle ends with the conversion of malic acid to oxaloacetic acid and begins a new cycle. This cycle reforms oxaloacetic acid in one cycle, producing two molecules of carbon dioxide and 15 molecules of ATP. The hydrogen atoms released from the intermediate compounds formed during the circulation are finally transferred to oxygen through the electron transfer system. Oxidation of hydrogen atoms by oxygen converts and stores a large amount of energy in foods consumed by aerobic organisms into ATP. These reactions, known as oxidative phosphorylation, are the most important means of producing ATP, the energy form available to organisms.
이와 같이 TCA 사이클은 인체의 기본 신진대사로서 에너지 및 살아가는데 필요한 필수물질을 생성 및 공급하는 기본 구조를 형성하게 된다. 따라서, 각종 공해, 스트레스 등에 의해서 TCA 사이클에 장애가 생기면 건강을 잃는 것은 물론이고, 심하면 생을 영위할 수 없게 되는 것이다.As such, the TCA cycle is the basic metabolism of the human body and forms the basic structure for producing and supplying energy and essential materials for living. Therefore, if the TCA cycle is interrupted by various pollutions, stress, etc., not only will they lose their health, but if they are severe, they will not be able to live their lives.
예를 들어, 당뇨병도 인슐린 생성에 장애가 생겨서 발생하는 병인데, 인슐린은 췌장의 랑겔한스섬의 β세포에서 먼저 프로인슐린(분자량 9,000)이 합성되고 분해효소인 트립신과 Zn++에 의해서 인슐린(분자량 6.500)이 합성된다. 췌장에 산소부족이나 트립신 및 아연 이온이 부족하면 발생될 수 있다.For example, diabetes mellitus is a disease caused by disorders in insulin production. Insulin is first synthesized in the pancreatic Langenhans' β cells, and is synthesized by proinsulin (molecular weight 9,000) and is released by the enzymes trypsin and Zn ++ (molecular weight 6.500). Is synthesized. It can be caused by lack of oxygen or lack of trypsin and zinc ions in the pancreas.
이와 같이 인체의 신진대사에는 각종 영양분, 물, 산소, 각종 비타민류, 각종 미네랄이 필수 불가결한 것이다.As such, various nutrients, water, oxygen, various vitamins, and various minerals are indispensable for the metabolism of the human body.
따라서, 본 발명에서는 이와 같은 TCA 사이클 이론에 근거하여, 상기 사이클을 활성화하기 위하여 필요한 각종 성분들을 제공할 수 있는 천연 약리성분, 즉 영지 또는 상황버섯, 복령, 인진쑥, 맥주효모, 죽염 그리고 유산균 또는 사상자를 포함하는 건강보조식품을 제공한다. 본 발명의 천연 약리성분을 모두 함유하는 건강보조식품은 종래에 개발되지 않는 것이다.Therefore, in the present invention, based on the TCA cycle theory, natural pharmacological components that can provide various components necessary for activating the cycle, namely ganoderma lucidum or edible mushroom, bokyeong, jinjin mugwort, beer yeast, bamboo salt and lactic acid bacteria or casualties It provides a health supplement comprising a. Health supplements containing all of the natural pharmacological components of the present invention is not developed conventionally.
여기서, 영지는 다당류 54-56%, 목질분 13-14%, 수분 12-13%, 소지방 1.9-2%, 전질소 1.6-2%, 포도당 4-5%, 화분류 0.022%, 게르마늄 800-2000 PPM 및 그외 아미노산, 효소, 무기물 등이 함유되어 있다(북경의학원 분석자료: 영지의 성분 분석).Here, Ganoderma lucidum 54-56%, wood flour 13-14%, moisture 12-13%, small fat 1.9-2%, total nitrogen 1.6-2%, glucose 4-5%, pollen 0.022%, germanium 800- It contains 2000 PPM and other amino acids, enzymes and minerals.
영지의 한의학적 효과로서는, 혈액을 정화시켜 혈류를 돕기 때문에 췌장의 기능을 정상적으로 이끌어 당뇨병에 효과 있는 외에, 혈압, 정력보강, 급/만성 위간염, 위염 및 위궤양 등의 소화기계 질환의 치료, 알레르기성 기관지염 또는 기관지천식 등의 호흡기계 질환의 치료 및 간장병 등에 효과가 있다.Ganoderma lucidum's medicinal effect helps to cleanse the blood and help the blood flow to the pancreas, leading to normal diabetes, and treatment of digestive system diseases such as blood pressure, energy enhancement, acute / chronic gastric hepatitis, gastritis and gastric ulcer, allergic It is effective in treating respiratory diseases such as bronchitis or bronchial asthma and liver disease.
복령은 소변을 잘 나오게 하고, 마음을 안정시키며 위장을 튼튼하게 한다. 그 성분은 에르고스테롤, 각종 미네랄, 다당류, 소량의 비타민류 등이다.Bokryeong makes urine well, calms the mind and strengthens the stomach. Its components are ergosterol, various minerals, polysaccharides, small amounts of vitamins and the like.
인진쑥중 생잎에는 수분 76.7%, 단백질 4.7%, 지질 1.9%, 탄수화물 14.5%, 회분 2.2% 및 무기질로서 칼슘 133.1mg, 나트륨 3.1mg, 칼륨 915.8mg, 인 173.1mg, 철분 173.1mg이 함유되어 있다. 무기질 중에는 칼슘, 인, 칼륨 그리고 철분이 많이 들어 있는데, 특히 칼륨의 함량이 대단히 높기 때문에 알카리성을 띨뿐만 아니라, 우리 몸에서 소화 흡수되고 대사되어 나갈 때 나트륨과 함께 배설되므로 염분섭취가 많은 우리나라와 같은 경우 인진쑥의 이용은 대단히 바람직하다.The fresh leaves of Phlox eryngii contain 76.7% moisture, 4.7% protein, 1.9% lipid, 14.5% carbohydrate, 2.2% ash, and 133.1 mg calcium, 3.1 mg sodium, 915.8 mg phosphorus, 173.1 mg phosphorus, and 173.1 mg iron as minerals. Minerals contain a lot of calcium, phosphorus, potassium and iron. Especially, because potassium is very high, it not only gives alkalinity but also excretes with sodium when it is digested, absorbed and metabolized in our body. In this case, the use of jinjin is very desirable.
또한 인진쑥 생줄기에는 수분 45.8%, 단백질 1.5%, 지질 0.8%, 탄수화물50.7%, 회분 1.2%, 무기질로서 칼슘 107.4mg, 나트륨 3.5mg, 칼륨 424.7mg, 인 51.2mg 그리고 철분이 1.3mg 함유되어 있다. 인진쑥 생뿌리에는 수분 59.5%, 단백질 1.6%, 지질 1.5%, 탄수화물 32.5%, 회분 4.8% 함유되어 있고, 무기질로서 칼슘 82.8mg, 나트륨 20.8mg, 칼륨 344.2mg, 인 82.1mg, 철분이 42.6mg 함유되어 있다. 인진쑥 건조잎에는 수분 12.2%, 단백질 18.1%, 지질 7.7%, 탄수화물 52.8%, 회분이 9.2% 함유되어 있으며, 무기질로서 칼슘 322.2mg, 나트륨 14.6mg, 칼륨 3238.3mg, 인 1114.9mg 그리고 철분이 24.5mg 함유되어 있다.In addition, the main stem of the mugwort contains 45.8% moisture, 1.5% protein, 0.8% lipid, 50.7% carbohydrate, 1.2% ash, 107.4mg calcium, 3.5mg sodium, 424.7mg potassium, 54.7mg phosphorus and 1.3mg iron. . Roots of the Roots of the Root Root contains 59.5% of moisture, 1.6% of protein, 1.5% of lipids, 32.5% of carbohydrates, and 4.8% of ash.The mineral contains 82.8 mg of calcium, 20.8 mg of sodium, 344.2 mg of potassium, 82.1 mg of phosphorus, and 42.6 mg of iron. It is. The dried leaves of Phosphorus wormwood contains 12.2% moisture, 18.1% protein, 7.7% lipid, 52.8% carbohydrate, 9.2% ash, and as minerals, 322.2 mg calcium, 14.6 mg sodium, 3238.3 mg potassium, 1114.9 mg phosphorus, and 24.5 mg iron. It is contained.
맥주효모 100g중 주요성분의 함량은 다음과 같으며(열량 : 367 Kcal), 그 효능은 간장질환과 피부미용, 신진대사 촉진, 성장촉진 및 두뇌개발 등이다.The content of major components in 100g of beer yeast is as follows (calories: 367 Kcal), and its effects are liver disease and skin beauty, promoting metabolism, promoting growth and developing brain.
일반성분General ingredient
탄수화물 37%, 단백질 47%, 지방 3%, 비타민 A 92mg, 비타민 C 1000mg, 비타민 E 160mg, 비타민 B1 12mg, 비타민 B2 3mg, 비타민 B3 35mg, 비타민 B5 3mg, 비타민 B6 2.5mg, 비타민 B9(엽산) 2.25mg, 비타민 B12 0.004mg, 비오틴(Bh) 0.075mg 및 콜린 350mg.Carbohydrate 37%, Protein 47%, Fat 3%, Vitamin A 92mg, Vitamin C 1000mg, Vitamin E 160mg, Vitamin B1 12mg, Vitamin B2 3mg, Vitamin B3 35mg, Vitamin B5 3mg, Vitamin B6 2.5mg, Vitamin B9 (Folic Acid) 2.25 mg, vitamin B12 0.004 mg, biotin (Bh) 0.075 mg and choline 350 mg.
미네랄, 미량 원소Minerals, trace elements
칼륨 1810mg, 망간 0.45mg, 인 950mg, 철분 7mg, 구리 0.55mg, 아연 6.5mg 및 이외에 크롬, 셀레늄, 핵산, 필수 아미노산 등을 함유하고 있다.It contains 1810 mg potassium, 0.45 mg manganese, 950 mg phosphorus, 7 mg iron, 0.55 mg copper, 6.5 mg zinc and other chromium, selenium, nucleic acids and essential amino acids.
유산균(lactic acid bacteria)은 자연계에 널리 존재하며 탄수화물을 혐기적으로 이용하여 유산을 생산하는 미생물이다. 유산균은 직접 혹은 간접적으로 식품에 첨가되어 이들의 대사산물인 유산에 의하여 식품의 저장성을 향상시키며, 식품의 향미와 조직을 개선한다. 발효식품을 통하여 섭취된 유산균은 장내로 유입된 후, 장내 상피세포에 착생하게 되어 병원성 미생물의 저해 및 길항작용, 면역활성의 증진, 암 발생률의 감소, 그리고 발암 원인성 효소의 감소 등 숙주 동물에 많은 도움을 준다. 따라서 유산균은 동서양을 막론하고 유제품, 육제품, 침채류 및 각종 젓갈류의 가공에 유용한 보조수단 뿐만 아니라 생균제(probiotics)로도 이용되고 있다.Lactic acid bacteria are microorganisms that exist widely in nature and produce lactic acid by using carbohydrates anaerobicly. Lactic acid bacteria are added directly or indirectly to foods to improve the shelf life of foods by their metabolites, lactic acid, improve the flavor and texture of foods. Lactic acid bacteria ingested through fermented food enters the intestine and enters the intestinal epithelial cells, thereby inhibiting and antagonizing pathogenic microorganisms, enhancing immune activity, reducing cancer incidence, and reducing carcinogenic enzymes. It helps a lot. Therefore, lactic acid bacteria are used as probiotics as well as auxiliary means useful for the processing of dairy products, meat products, sesame and various salted fish in both East and West.
죽염은 천일염을 대나무통에 넣고 섭씨 약 1300 ℃에서 9번 구운 것을 말하는데, 천일염에는 소위 홀리세븐(holly seven)이라는 바다에 화학적으로 안정되어 있어 증발도 침전도 되지 않는 7가지 물질을 함유하고 있으며, 이것을 높은 온도로 구울 때 기체성분은 휘발되어 없어지고 고체성분 즉 금속성분이 대부분 이온화된다. K+, Na+, Ca++, Mg++ 등의 무기물 등을 함유하며, 상기 구성성분의 상호작용으로 우리 몸의 신진대사를 촉진시킨다.Bamboo salt refers to sun-dried salt in bamboo barrel and baked 9 times at about 1300 ℃. The sun salt contains seven substances that are chemically stable in the so-called holly seven and do not evaporate or settle. When it is baked at a high temperature, the gaseous components are volatilized away and most of the solid components, that is, the metal components, are ionized. It contains minerals such as K +, Na +, Ca ++, Mg ++ and the like, and promotes the metabolism of our body by the interaction of the components.
사상자(蛇床子= 뱀도라지 씨)는 산형과(傘形科; Umbelliferae) 식물인 사상(蛇床 벌사상자; Cnidium monieri(L.) Cuss.)의 果實이며, 그 주성분은 쿠마린 (coumarin), 오스톨(osthol) 및 휘발성 오일(volatile oils)이다.Casualties are the fruit of the umbelliferae plant, Cnidium monieri (L.) Cuss., Whose main components are coumarin and o Osthol and volatile oils.
본 발명의 건강보조식품은 양질의 복령 2g, 인진쑥 2g, 죽염 0.3g을 분쇄하고, 여기에 맥주효모 3g을 합하고, 또한 영지 또는 상황버섯 5g을 추출액으로 하여 냉동(질소가스 존재하, 섭씨 -195.8 ℃) 건조하여 흡착시키고, 다시 한번 풍건하여 과립으로 하고, 유산균 2g을 넣고 환으로 하여 제조한다. 또한 그 복용량은 1일 3회분으로 한다.The dietary supplement of the present invention is crushed 2g of good quality Fuling, 2g of Injin mugwort, 0.3g of bamboo salt, and 3g of brewer's yeast, and 5g of Ganoderma lucidum or situation mushroom as an extract (free of nitrogen gas, -195.8 degrees Celsius). ℃) dried, adsorbed, air-dried once again to form granules, and 2g of lactic acid bacteria were prepared into a ring. In addition, the dose is three times a day.
이상 기술한 바와 같이, 본 발명에 의하면 인체의 에너지 형태인 ATP를 생성하는 기본 대사인 TCA 사이클에 필요한 각종 성분들을 제공할 수 있는 천연 약리성분을 함유하는 건강식품을 제공한다. 본 발명의 건강보조식품은 종합적이고 과학적인 신진대사를 촉진할 수 있음은 물론 기능성이 풍부하고 쉽고 편리하게 복용할 수 있다.As described above, the present invention provides a health food containing natural pharmacological components capable of providing various components necessary for the TCA cycle, which is a basic metabolism that produces ATP, which is the energy form of the human body. The health supplement of the present invention can promote comprehensive and scientific metabolism, as well as rich in functionality and can be easily and conveniently taken.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020061356A KR20040032288A (en) | 2002-10-09 | 2002-10-09 | Health food comprising natural Ganoderma Lucidum Karst components and method for the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020061356A KR20040032288A (en) | 2002-10-09 | 2002-10-09 | Health food comprising natural Ganoderma Lucidum Karst components and method for the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20040032288A true KR20040032288A (en) | 2004-04-17 |
Family
ID=37332200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020061356A KR20040032288A (en) | 2002-10-09 | 2002-10-09 | Health food comprising natural Ganoderma Lucidum Karst components and method for the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20040032288A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008035442A1 (en) | 2008-07-26 | 2010-01-28 | Ernst-Moritz-Arndt-Universität Greifswald | Preparations from Artemisia Annua, their transformation into micro- and nanoparticles and their use |
DE102008035443A1 (en) | 2008-07-26 | 2010-04-29 | Ernst-Moritz-Arndt-Universität Greifswald | Surfactant-free emulsions with anti-aging effect, their preparation and their use |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000037814A (en) * | 1998-12-02 | 2000-07-05 | 최수부 | Healthy food contained natural medicine materials |
KR20000037815A (en) * | 1998-12-02 | 2000-07-05 | 최수부 | Healthy food contained natural medicine materials |
KR20020012434A (en) * | 2000-08-07 | 2002-02-16 | 한완석 | Healthy food composition for protecting hepatic |
KR20020019116A (en) * | 2002-02-15 | 2002-03-09 | 김태룡 | A method of preparing a blocked formulation comprising uncooked food materials |
KR20020018844A (en) * | 2000-09-04 | 2002-03-09 | 엄성희, 김판구 | The uncooked food for glucose control of a diabetic and method of manufacture |
KR20020025143A (en) * | 2002-03-05 | 2002-04-03 | 김수경 | The uncooked food for care fatty liver and method thereof |
-
2002
- 2002-10-09 KR KR1020020061356A patent/KR20040032288A/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000037814A (en) * | 1998-12-02 | 2000-07-05 | 최수부 | Healthy food contained natural medicine materials |
KR20000037815A (en) * | 1998-12-02 | 2000-07-05 | 최수부 | Healthy food contained natural medicine materials |
KR20020012434A (en) * | 2000-08-07 | 2002-02-16 | 한완석 | Healthy food composition for protecting hepatic |
KR20020018844A (en) * | 2000-09-04 | 2002-03-09 | 엄성희, 김판구 | The uncooked food for glucose control of a diabetic and method of manufacture |
KR20020019116A (en) * | 2002-02-15 | 2002-03-09 | 김태룡 | A method of preparing a blocked formulation comprising uncooked food materials |
KR20020025143A (en) * | 2002-03-05 | 2002-04-03 | 김수경 | The uncooked food for care fatty liver and method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008035442A1 (en) | 2008-07-26 | 2010-01-28 | Ernst-Moritz-Arndt-Universität Greifswald | Preparations from Artemisia Annua, their transformation into micro- and nanoparticles and their use |
DE102008035443A1 (en) | 2008-07-26 | 2010-04-29 | Ernst-Moritz-Arndt-Universität Greifswald | Surfactant-free emulsions with anti-aging effect, their preparation and their use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3138414B1 (en) | Comprehensive nutrition powder and preparation method therefor | |
US8883137B2 (en) | Compositions comprising selenium-rich yeast and yeast beta-glucan | |
CN104982928B (en) | A kind of japanese yew fruit health care ferment and preparation method thereof | |
KR101183605B1 (en) | The beverage composition for anti-hangover functional using cucumber vinegar | |
CN101658537B (en) | Hypoglycemic ferment compound and its preparation method | |
CN102389078A (en) | Manufacture process of compound grain | |
CN100362091C (en) | A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug | |
KR102299934B1 (en) | Composition for preventing or treating liver damage by alcohol which is excellent in hangover resolution | |
KR101695038B1 (en) | Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy | |
CN1711859A (en) | Fermented milk sheets with auxin | |
Xu et al. | Effect of selenium on mushroom growth and metabolism: A review | |
CN104304577A (en) | Biological beverage with camellia chrysantha as carrier and preparation method thereof | |
CN1736220A (en) | Anti-fatigue yoghurt tablet | |
JP2011178700A (en) | Tablet and method for producing the same | |
KR20070105486A (en) | Tea and tea manufacturing method for improving liver function and curing of hangover | |
KR100945462B1 (en) | Food composition for detoxificating heavy metal and health food comprising the same | |
CN104711203A (en) | Selenium-rich germanium yeast powder | |
KR20160055292A (en) | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
KR20040032288A (en) | Health food comprising natural Ganoderma Lucidum Karst components and method for the same | |
KR100760983B1 (en) | A red pepper paste added garlic and its making method | |
CN1711856A (en) | Fe contained yoghurt sheets for treating anemia | |
KR101264744B1 (en) | Manufacturing Method of Fermented Media using CHEJU Scoria and Nutriculture Method and Functional Materials for Preventing and Treating of Thereof Manufacturing | |
KR20150067822A (en) | Functional composition for comprising wild-peach and the manufacturing method thereof | |
KR102030576B1 (en) | A method for promoting fermentation of wild plants using mineral balls and a fermented extract of wild plants | |
CN112106864A (en) | Selenium-enriched toadstool-based burdock hypha fermented tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |